vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.

RE/MAX Holdings, Inc. is the larger business by last-quarter revenue ($71.1M vs $40.7M, roughly 1.7× PETMED EXPRESS INC). RE/MAX Holdings, Inc. runs the higher net margin — 2.0% vs -26.0%, a 28.0% gap on every dollar of revenue. On growth, RE/MAX Holdings, Inc. posted the faster year-over-year revenue change (-1.8% vs -23.3%). RE/MAX Holdings, Inc. produced more free cash flow last quarter ($33.5M vs $-9.2M). Over the past eight quarters, RE/MAX Holdings, Inc.'s revenue compounded faster (-4.7% CAGR vs -20.9%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.

PETS vs RMAX — Head-to-Head

Bigger by revenue
RMAX
RMAX
1.7× larger
RMAX
$71.1M
$40.7M
PETS
Growing faster (revenue YoY)
RMAX
RMAX
+21.4% gap
RMAX
-1.8%
-23.3%
PETS
Higher net margin
RMAX
RMAX
28.0% more per $
RMAX
2.0%
-26.0%
PETS
More free cash flow
RMAX
RMAX
$42.7M more FCF
RMAX
$33.5M
$-9.2M
PETS
Faster 2-yr revenue CAGR
RMAX
RMAX
Annualised
RMAX
-4.7%
-20.9%
PETS

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
RMAX
RMAX
Revenue
$40.7M
$71.1M
Net Profit
$-10.6M
$1.4M
Gross Margin
23.3%
Operating Margin
-25.7%
13.1%
Net Margin
-26.0%
2.0%
Revenue YoY
-23.3%
-1.8%
Net Profit YoY
-1392.6%
-75.2%
EPS (diluted)
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
RMAX
RMAX
Q4 25
$40.7M
$71.1M
Q3 25
$44.4M
$73.2M
Q2 25
$51.2M
$72.8M
Q1 25
$50.8M
$74.5M
Q4 24
$52.0M
$72.5M
Q3 24
$58.0M
$78.5M
Q2 24
$66.2M
$78.5M
Q1 24
$65.1M
$78.3M
Net Profit
PETS
PETS
RMAX
RMAX
Q4 25
$-10.6M
$1.4M
Q3 25
$-8.5M
$4.0M
Q2 25
$-34.2M
$4.7M
Q1 25
$-11.6M
$-2.0M
Q4 24
$-707.0K
$5.8M
Q3 24
$2.3M
$966.0K
Q2 24
$3.8M
$3.7M
Q1 24
$-5.0M
$-3.4M
Gross Margin
PETS
PETS
RMAX
RMAX
Q4 25
23.3%
Q3 25
28.0%
Q2 25
28.1%
Q1 25
29.9%
Q4 24
31.0%
Q3 24
32.3%
Q2 24
28.8%
Q1 24
29.3%
Operating Margin
PETS
PETS
RMAX
RMAX
Q4 25
-25.7%
13.1%
Q3 25
-18.9%
25.0%
Q2 25
-66.7%
19.3%
Q1 25
-11.9%
7.2%
Q4 24
-0.9%
5.9%
Q3 24
1.0%
19.4%
Q2 24
6.6%
20.6%
Q1 24
-5.9%
5.8%
Net Margin
PETS
PETS
RMAX
RMAX
Q4 25
-26.0%
2.0%
Q3 25
-19.2%
5.4%
Q2 25
-66.7%
6.4%
Q1 25
-22.9%
-2.6%
Q4 24
-1.4%
8.0%
Q3 24
4.0%
1.2%
Q2 24
5.7%
4.7%
Q1 24
-7.7%
-4.3%
EPS (diluted)
PETS
PETS
RMAX
RMAX
Q4 25
$-0.50
Q3 25
$-0.41
Q2 25
$-1.65
Q1 25
$-0.56
Q4 24
$-0.03
Q3 24
$0.11
Q2 24
$0.18
Q1 24
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
RMAX
RMAX
Cash + ST InvestmentsLiquidity on hand
$26.9M
$118.7M
Total DebtLower is stronger
$432.2M
Stockholders' EquityBook value
$32.8M
$452.4M
Total Assets
$88.0M
$582.5M
Debt / EquityLower = less leverage
0.96×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
RMAX
RMAX
Q4 25
$26.9M
$118.7M
Q3 25
$36.1M
$107.5M
Q2 25
$41.1M
$94.3M
Q1 25
$54.7M
$89.1M
Q4 24
$50.1M
$96.6M
Q3 24
$52.0M
$83.8M
Q2 24
$46.0M
$66.1M
Q1 24
$55.3M
$82.1M
Total Debt
PETS
PETS
RMAX
RMAX
Q4 25
$432.2M
Q3 25
$433.3M
Q2 25
$434.4M
Q1 25
$435.3M
Q4 24
$436.2M
Q3 24
$437.2M
Q2 24
$438.1M
Q1 24
$439.0M
Stockholders' Equity
PETS
PETS
RMAX
RMAX
Q4 25
$32.8M
$452.4M
Q3 25
$43.1M
$448.1M
Q2 25
$51.5M
$442.4M
Q1 25
$85.1M
$433.5M
Q4 24
$96.2M
$429.5M
Q3 24
$96.4M
$423.1M
Q2 24
$93.5M
$418.4M
Q1 24
$96.7M
$412.0M
Total Assets
PETS
PETS
RMAX
RMAX
Q4 25
$88.0M
$582.5M
Q3 25
$100.3M
$582.2M
Q2 25
$109.8M
$574.8M
Q1 25
$148.7M
$571.4M
Q4 24
$144.8M
$581.6M
Q3 24
$146.0M
$578.6M
Q2 24
$152.7M
$571.4M
Q1 24
$169.9M
$566.7M
Debt / Equity
PETS
PETS
RMAX
RMAX
Q4 25
0.96×
Q3 25
0.97×
Q2 25
0.98×
Q1 25
1.00×
Q4 24
1.02×
Q3 24
1.03×
Q2 24
1.05×
Q1 24
1.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
RMAX
RMAX
Operating Cash FlowLast quarter
$-9.2M
$40.9M
Free Cash FlowOCF − Capex
$-9.2M
$33.5M
FCF MarginFCF / Revenue
-22.7%
47.1%
Capex IntensityCapex / Revenue
0.1%
10.4%
Cash ConversionOCF / Net Profit
28.39×
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$56.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
RMAX
RMAX
Q4 25
$-9.2M
$40.9M
Q3 25
$-2.2M
$17.7M
Q2 25
$-12.3M
$4.6M
Q1 25
$7.0M
$5.7M
Q4 24
$-1.2M
$59.7M
Q3 24
$7.4M
$17.6M
Q2 24
$-8.5M
$15.9M
Q1 24
$7.1M
$9.4M
Free Cash Flow
PETS
PETS
RMAX
RMAX
Q4 25
$-9.2M
$33.5M
Q3 25
$-4.8M
$16.4M
Q2 25
$-13.6M
$2.9M
Q1 25
$4.6M
$4.0M
Q4 24
$-1.9M
$53.0M
Q3 24
$6.1M
$16.3M
Q2 24
$-9.2M
$14.0M
Q1 24
$5.9M
$6.8M
FCF Margin
PETS
PETS
RMAX
RMAX
Q4 25
-22.7%
47.1%
Q3 25
-10.8%
22.4%
Q2 25
-26.5%
4.0%
Q1 25
9.1%
5.3%
Q4 24
-3.7%
73.2%
Q3 24
10.6%
20.8%
Q2 24
-13.9%
17.8%
Q1 24
9.0%
8.6%
Capex Intensity
PETS
PETS
RMAX
RMAX
Q4 25
0.1%
10.4%
Q3 25
5.9%
1.8%
Q2 25
2.5%
2.2%
Q1 25
4.7%
2.3%
Q4 24
1.5%
9.1%
Q3 24
2.2%
1.7%
Q2 24
1.0%
2.4%
Q1 24
1.9%
3.3%
Cash Conversion
PETS
PETS
RMAX
RMAX
Q4 25
28.39×
Q3 25
4.45×
Q2 25
0.97×
Q1 25
Q4 24
10.28×
Q3 24
3.18×
18.22×
Q2 24
-2.27×
4.29×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

RMAX
RMAX

Franchising Segment$50.1M70%
Broker Fees$13.9M20%
Annual Dues$7.4M10%

Related Comparisons